Key result
Endovascular aortic repair in high-surgical-risk patients with aortic pathologies was associated with a 1-month perioperative mortality rate of 10%.
Observational (n=30)
No
Answers are grounded in this paper and cite their sources.
Endovascular aortic repair (EVAR/TEVAR) is a feasible and safe alternative for high-risk surgical patients with aortic pathologies, with acceptable short-term mortality and complication rates.
Objective: The aim of this study is sharing of our endovascular aortic repair experiments in patients with high risk for surgery and contributing to literature with comparing previous report according to mortality complications and additional operations.Methods: Patients with endovascular aortic repair application were evaluated retrospectively.Perioperative one month mortality, additional applications during procedure, occurred complications, endoleak types, approaching anesthetical technique, diagnosis of disease, comorbid factors and demographical data registered.Results were compared with data in the literature Results: Abdominal endovascular aortic repair (EVAR) applicated into 19 patients.Thoracic endovascular aortic repair (TEVAR) applicated into 11 patients.EVAR patients were operated with diagnosis of abdominal aortic aneurysm.Nine of these patients were emergely operated due to rupture.TEVAR applicated 8 patients were operated due to Type 3 Aortic Dissection and 1 patient was operated due to transsection.One month mortality of all patients were found as 10% (three patients).Endoleaks were occurred 6 patients: Three of them were Type 1a, two of them were Type1b and one of them was Type2.Balloon angioplasty applicated in two patients due to Type 1a endoleak and, in one patient due to Type 1b endoleak.Chronic renal failure was developed in one patient (3.3%) due to contrast nephropathy.Reexploration was applicated in two patients (6.7%) due to hematoma.Conclusion: Endovascular techniques are become frequently preferred treatment modality with the developing technology.We believed that endovascular approaches are safely preferable alternative in patients with high surgical risk as our series.
No takes yet. Share an insight, caveat, or question.
Sinan Demirtaş (2014) conducted an observational in Aortic pathologies (aneurysms, dissections, transections) (n=30). Endovascular aortic repair (EVAR and TEVAR) was evaluated on Perioperative 1-month mortality. Endovascular aortic repair in high-surgical-risk patients with aortic pathologies was associated with a 1-month perioperative mortality rate of 10%.
Synapse has enriched 10 related papers. Consider them for comparative context: